Edwards Lifesciences Corp (EW)
86.46
-0.78
(-0.89%)
USD |
NYSE |
Apr 18, 16:00
86.46
0.00 (0.00%)
After-Hours: 20:00
Edwards Lifesciences Cash from Investing (TTM): 173.80M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 173.80M |
| September 30, 2023 | 254.40M |
| June 30, 2023 | -36.10M |
| March 31, 2023 | 23.30M |
| December 31, 2022 | 252.30M |
| September 30, 2022 | -808.30M |
| June 30, 2022 | -984.20M |
| March 31, 2022 | -1.443B |
| December 31, 2021 | -1.722B |
| September 30, 2021 | -1.016B |
| June 30, 2021 | -765.40M |
| March 31, 2021 | -446.10M |
| December 31, 2020 | -531.10M |
| September 30, 2020 | -716.50M |
| June 30, 2020 | -602.90M |
| March 31, 2020 | -681.00M |
| December 31, 2019 | -595.80M |
| September 30, 2019 | -144.80M |
| June 30, 2019 | -386.30M |
| March 31, 2019 | -193.10M |
| December 31, 2018 | 76.70M |
| September 30, 2018 | 120.30M |
| June 30, 2018 | 165.00M |
| March 31, 2018 | -578.10M |
| December 31, 2017 | -647.20M |
| Date | Value |
|---|---|
| September 30, 2017 | -616.30M |
| June 30, 2017 | -402.90M |
| March 31, 2017 | -107.80M |
| December 31, 2016 | -211.70M |
| September 30, 2016 | -264.60M |
| June 30, 2016 | -444.10M |
| March 31, 2016 | -88.50M |
| December 31, 2015 | -316.10M |
| September 30, 2015 | -231.40M |
| June 30, 2015 | -210.60M |
| March 31, 2015 | -693.50M |
| December 31, 2014 | -633.00M |
| September 30, 2014 | -991.90M |
| June 30, 2014 | -943.60M |
| March 31, 2014 | -546.20M |
| December 31, 2013 | -412.70M |
| September 30, 2013 | -138.40M |
| June 30, 2013 | -163.80M |
| March 31, 2013 | -133.50M |
| December 31, 2012 | -78.80M |
| September 30, 2012 | -214.50M |
| June 30, 2012 | -27.30M |
| March 31, 2012 | -180.00M |
| December 31, 2011 | -406.50M |
| September 30, 2011 | -321.30M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.722B
Minimum
Dec 2021
254.40M
Maximum
Sep 2023
-535.63M
Average
-595.80M
Median
Dec 2019
Cash from Investing (TTM) Benchmarks
| Stryker Corp | -962.00M |
| Boston Scientific Corp | -2.574B |
| Abbott Laboratories | -3.133B |
| Align Technology Inc | -195.94M |
| Zimmer Biomet Holdings Inc | -778.90M |